bioAffinity Technologies (BIAF) Shares Outstanding (Weighted Average) (2021 - 2026)
bioAffinity Technologies has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $1.3 million for Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) fell 89.53% to $1.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Mar 2026, down 89.53% year-over-year, with the annual reading at $1.3 million for FY2025, 233.65% up from the prior year.
- Shares Outstanding (Weighted Average) was $1.3 million for Q1 2026 at bioAffinity Technologies, roughly flat from $1.3 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $24.0 million in Q2 2025 and troughed at $404167.0 in Q4 2024.
- The 5-year median for Shares Outstanding (Weighted Average) is $4.6 million (2022), against an average of $6.1 million.
- Year-over-year, Shares Outstanding (Weighted Average) tumbled 95.38% in 2024 and then skyrocketed 233.65% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $4.6 million in 2022, then skyrocketed by 88.12% to $8.7 million in 2023, then tumbled by 95.38% to $404167.0 in 2024, then skyrocketed by 233.65% to $1.3 million in 2025, then dropped by 0.01% to $1.3 million in 2026.
- Per Business Quant, the three most recent readings for BIAF's Shares Outstanding (Weighted Average) are $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $804604.0 (Q3 2025).